Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionnicotinic acid receptor activity

HCAR2 HCAR3

2.24e-052952GO:0070553
GeneOntologyMolecularFunctioninitiator methionyl aminopeptidase activity

METAP1D METAP1

2.22e-045952GO:0004239
GeneOntologyMolecularFunctionenzyme activator activity

ROCK2 APOA5 TSC2 ARHGAP35 CCNQ DPM2 MOB2 TBC1D1 SMCR8 ARHGAP21 ARAP2

2.83e-046569511GO:0008047
DomainMAP_1

METAP1D METAP1

2.51e-052942PS00680
DomainHCAR2/3_rcpt

HCAR2 HCAR3

2.51e-052942IPR028017
DomainPept_M24A_MAP1

METAP1D METAP1

2.51e-052942IPR002467
DomainPept_M24_MAP

METAP1D METAP1

7.49e-053942IPR001714
Domain-

UBASH3A UBASH3B

2.48e-0459423.90.1140.10
DomainDUF3398

DOCK8 DOCK10

3.71e-046942PF11878
DomainDOCK_C/D_N

DOCK8 DOCK10

3.71e-046942IPR021816
DomainRNA_ligase/cNuc_Pdiesterase

UBASH3A UBASH3B

3.71e-046942IPR009097
DomainSIX1_SD

SIX1 SIX2

5.18e-047942PF16878
DomainSIX1_SD

SIX1 SIX2

5.18e-047942IPR031701
DomainPept_M24

METAP1D METAP1

8.82e-049942IPR000994
DomainPeptidase_M24

METAP1D METAP1

8.82e-049942PF00557
Domain-

METAP1D METAP1

8.82e-0499423.90.230.10
DomainDOCK_C

DOCK8 DOCK10

1.34e-0311942IPR010703
DomainDHR-1_domain

DOCK8 DOCK10

1.34e-0311942IPR027007
DomainDHR_2

DOCK8 DOCK10

1.34e-0311942PS51651
DomainDHR_1

DOCK8 DOCK10

1.34e-0311942PS51650
DomainDOCK-C2

DOCK8 DOCK10

1.34e-0311942PF14429
DomainDHR-2

DOCK8 DOCK10

1.34e-0311942IPR027357
DomainDHR-2

DOCK8 DOCK10

1.34e-0311942PF06920
DomainDOCK

DOCK8 DOCK10

1.34e-0311942IPR026791
DomainHis_Phos_1

UBASH3A UBASH3B

1.60e-0312942PF00300
DomainHis_Pase_superF_clade-1

UBASH3A UBASH3B

1.60e-0312942IPR013078
DomainRhoGAP

ARHGAP35 ARHGAP21 ARAP2

3.77e-0362943SM00324
DomainRhoGAP

ARHGAP35 ARHGAP21 ARAP2

3.94e-0363943PF00620
DomainRHOGAP

ARHGAP35 ARHGAP21 ARAP2

4.12e-0364943PS50238
DomainRhoGAP_dom

ARHGAP35 ARHGAP21 ARAP2

4.12e-0364943IPR000198
Domain-

ARHGAP35 ARHGAP21 ARAP2

4.12e-03649431.10.555.10
DomainHis_PPase_superfam

UBASH3A UBASH3B

4.49e-0320942IPR029033
Domain-

UBASH3A UBASH3B

4.49e-03209423.40.50.1240
DomainPH

ROCK2 DOCK10 BMX ARHGAP21 ARAP2

6.02e-03229945PF00169
PathwayREACTOME_RHO_GTPASE_CYCLE

ROCK2 DOCK8 CFTR DOCK10 DBT ARHGAP35 ZAP70 NISCH ARHGAP21 ARAP2

5.08e-054396910MM15595
PathwayREACTOME_RHOJ_GTPASE_CYCLE

DOCK8 ARHGAP35 ARHGAP21

6.00e-0516693MM15605
PathwayREACTOME_RHO_GTPASE_CYCLE

ROCK2 DOCK8 CFTR DOCK10 DBT ARHGAP35 ZAP70 NISCH ARHGAP21 ARAP2

6.26e-054506910M27078
PathwayREACTOME_CDC42_GTPASE_CYCLE

DOCK8 DOCK10 ARHGAP35 ARHGAP21 ARAP2

9.50e-0594695MM15598
PathwayREACTOME_RAC1_GTPASE_CYCLE

DOCK8 DOCK10 ARHGAP35 NISCH ARHGAP21 ARAP2

2.11e-04175696MM15599
PathwayREACTOME_RAC1_GTPASE_CYCLE

DOCK8 DOCK10 ARHGAP35 NISCH ARHGAP21 ARAP2

2.76e-04184696M41809
PathwayREACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3

ROCK2 DOCK8 CFTR DOCK10 DBT ARHGAP35 ZAP70 NISCH ZW10 ARHGAP21 ARAP2

2.89e-046496911MM15690
Pubmed

International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B).

HCAR2 HCAR1 HCAR3

2.10e-08397321454438
Pubmed

Effects of high fat diet on GPR109A and GPR81 gene expression.

HCAR2 HCAR1 HCAR3

2.10e-08397322842580
Pubmed

Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases.

HCAR2 HCAR1 HCAR3

2.10e-08397334852802
Pubmed

Sts-2 is a phosphatase that negatively regulates zeta-associated protein (ZAP)-70 and T cell receptor signaling pathways.

UBASH3A ZAP70 UBASH3B

8.40e-08497321393235
Pubmed

Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors.

SIX1 DROSHA SIX2

8.40e-08497325670082
Pubmed

Peroxisome proliferator-activated receptor gamma regulates expression of the anti-lipolytic G-protein-coupled receptor 81 (GPR81/Gpr81).

HCAR2 HCAR1 HCAR3

8.40e-08497319633298
Pubmed

Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2.

UBASH3A ZAP70 UBASH3B

2.09e-07597314738763
Pubmed

Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors.

SIX1 DROSHA SIX2

2.09e-07597325670083
Pubmed

Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81.

HCAR2 HCAR1 HCAR3

2.09e-07597319047060
Pubmed

Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.

DOCK10 ARHGAP35 SALL2 ALMS1 TBC1D1 ZBTB40 NAV2 POFUT1

2.39e-0722597812168954
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

RTTN ADGRB2 TSC2 ARHGAP35 NPHP4 ZNF865 MEGF8 PTPRS RBM19 NISCH USP40 NAV2 POFUT1 ARHGAP21

2.37e-061105971435748872
Pubmed

K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8(+) T cell activation.

UBASH3A ZAP70 UBASH3B

4.54e-061297326390156
Pubmed

Members of the novel UBASH3/STS/TULA family of cellular regulators suppress T-cell-driven inflammatory responses in vivo.

UBASH3A UBASH3B

7.70e-06297225047644
Pubmed

Activated niacin receptor HCA2 inhibits chemoattractant-mediated macrophage migration via Gβγ/PKC/ERK1/2 pathway and heterologous receptor desensitization.

HCAR2 HCAR3

7.70e-06297228186140
Pubmed

TULA-2, a novel histidine phosphatase, regulates bone remodeling by modulating osteoclast function.

UBASH3A UBASH3B

7.70e-06297223149425
Pubmed

The Immunometabolomic Interface Receptor Hydroxycarboxylic Acid Receptor 2 Mediates the Therapeutic Effects of Dimethyl Fumarate in Autoantibody-Induced Skin Inflammation.

HCAR2 HCAR3

7.70e-06297230154797
Pubmed

The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival.

HCAR2 HCAR3

7.70e-06297224371223
Pubmed

High dietary niacin may increase prostaglandin formation but does not increase tumor formation in ApcMin/+ mice.

HCAR2 HCAR3

7.70e-06297221774590
Pubmed

Adrenaline-induced colonic K+ secretion is mediated by KCa1.1 (BK) channels.

CFTR KCNMA1

7.70e-06297220351045
Pubmed

The role of HCA2 (GPR109A) in regulating macrophage function.

HCAR2 HCAR3

7.70e-06297223882124
Pubmed

Crosstalk between microbiome, regulatory T cells and HCA2 orchestrates the inflammatory response in a murine psoriasis model.

HCAR2 HCAR3

7.70e-06297236891315
Pubmed

An unexpected 2-histidine phosphoesterase activity of suppressor of T-cell receptor signaling protein 1 contributes to the suppression of cell signaling.

UBASH3A UBASH3B

7.70e-06297232371395
Pubmed

GPR109a Regulates Phenotypic and Functional Alterations in Macrophages and the Progression of Type 1 Diabetes.

HCAR2 HCAR3

7.70e-06297236208084
Pubmed

Analysis of the mutational status of SIX1/2 and microRNA processing genes in paired primary and relapsed Wilms tumors and association with relapse.

SIX1 SIX2

7.70e-06297233281191
Pubmed

Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a.

HCAR2 HCAR3

7.70e-06297238007572
Pubmed

The role of the C-terminus of the human hydroxycarboxylic acid receptors 2 and 3 in G protein activation using Gα-engineered yeast cells.

HCAR2 HCAR3

7.70e-06297226656756
Pubmed

Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation.

HCAR2 HCAR3

7.70e-06297237597514
Pubmed

Mouse cystic fibrosis transmembrane conductance regulator forms cAMP-PKA-regulated apical chloride channels in cortical collecting duct.

CFTR KCNJ1

7.70e-06297220231442
Pubmed

The Role of GPR109a Signaling in Niacin Induced Effects on Fed and Fasted Hepatic Metabolism.

HCAR2 HCAR3

7.70e-06297233924461
Pubmed

Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE.

HCAR2 HCAR3

7.70e-06297224691444
Pubmed

Ketone Body 3-Hydroxybutyrate Ameliorates Atherosclerosis via Receptor Gpr109a-Mediated Calcium Influx.

HCAR2 HCAR3

7.70e-06297233977048
Pubmed

Hydroxycarboxylic acid receptors are essential for breast cancer cells to control their lipid/fatty acid metabolism.

HCAR1 HCAR3

7.70e-06297225839160
Pubmed

Butyrate ameliorates caerulein-induced acute pancreatitis and associated intestinal injury by tissue-specific mechanisms.

HCAR2 HCAR3

7.70e-06297231347703
Pubmed

PUMA-G, an IFN-gamma-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily.

HCAR2 HCAR3

7.70e-06297211745392
Pubmed

Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis.

HCAR2 HCAR3

7.70e-06297230659164
Pubmed

Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets.

HCAR2 HCAR3

7.70e-06297225622782
Pubmed

GPR109A mediates the effects of hippuric acid on regulating osteoclastogenesis and bone resorption in mice.

HCAR2 HCAR3

7.70e-06297233420329
Pubmed

Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium.

HCAR2 HCAR3

7.70e-06297219223991
Pubmed

Molecular identification of nicotinic acid receptor.

HCAR2 HCAR3

7.70e-06297212646212
Pubmed

PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect.

HCAR2 HCAR3

7.70e-06297212563315
Pubmed

Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice.

HCAR2 HCAR3

7.70e-06297223967184
Pubmed

Involvement of the Niacin Receptor GPR109a in the LocalControl of Glucose Uptake in Small Intestine of Type 2Diabetic Mice.

HCAR2 HCAR3

7.70e-06297226371038
Pubmed

Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease.

HCAR2 HCAR3

7.70e-06297234653248
Pubmed

Phenolic acids suppress adipocyte lipolysis via activation of the nicotinic acid receptor GPR109A (HM74a/PUMA-G).

HCAR2 HCAR3

7.70e-06297219136666
Pubmed

G Protein-Coupled Receptor 109A Maintains the Intestinal Integrity and Protects Against ETEC Mucosal Infection by Promoting IgA Secretion.

HCAR2 HCAR3

7.70e-06297233488584
Pubmed

Lactate-induced activation of HCA2 improves survival in mice with sepsis.

HCAR2 HCAR3

7.70e-06297230951370
Pubmed

Niacin Ameliorates Hepatic Steatosis by Inhibiting De Novo Lipogenesis Via a GPR109A-Mediated PKC-ERK1/2-AMPK Signaling Pathway in C57BL/6 Mice Fed a High-Fat Diet.

HCAR2 HCAR3

7.70e-06297231858105
Pubmed

Deficiency of metabolite sensing receptor HCA2 impairs the salutary effect of niacin in hemorrhagic shock.

HCAR2 HCAR3

7.70e-06297230625381
Pubmed

Exploring the role of the metabolite-sensing receptor GPR109a in diabetic nephropathy.

HCAR2 HCAR3

7.70e-06297232068460
Pubmed

The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome.

HCAR2 HCAR3

7.70e-06297230657794
Pubmed

Ketones and pain: unexplored role of hydroxyl carboxylic acid receptor type 2 in the pathophysiology of neuropathic pain.

HCAR2 HCAR3

7.70e-06297230085883
Pubmed

Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation.

HCAR2 HCAR3

7.70e-06297221655214
Pubmed

Melatonin alleviates titanium nanoparticles induced osteolysis via activation of butyrate/GPR109A signaling pathway.

HCAR2 HCAR3

7.70e-06297234092246
Pubmed

(D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G.

HCAR2 HCAR3

7.70e-06297215929991
Pubmed

The Phosphatases STS1 and STS2 Regulate Hematopoietic Stem and Progenitor Cell Fitness.

UBASH3A UBASH3B

7.70e-06297226365512
Pubmed

Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models.

HCAR2 HCAR3

7.70e-06297236991440
Pubmed

Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages.

HCAR2 HCAR3

7.70e-06297225320346
Pubmed

Molecular identification of high and low affinity receptors for nicotinic acid.

HCAR2 HCAR3

7.70e-06297212522134
Pubmed

Nicotinic acid inhibits glucose-stimulated insulin secretion via the G protein-coupled receptor PUMA-G in murine islet β cells.

HCAR2 HCAR3

7.70e-06297221441844
Pubmed

G Protein-Coupled Receptor 109A and Host Microbiota Modulate Intestinal Epithelial Integrity During Sepsis.

HCAR2 HCAR3

7.70e-06297230271409
Pubmed

Niacin fine-tunes energy homeostasis through canonical GPR109A signaling.

HCAR2 HCAR3

7.70e-06297230596513
Pubmed

The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer's disease.

HCAR2 HCAR3

7.70e-06297235320002
Pubmed

GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.

HCAR2 HCAR3

7.70e-06297216322797
Pubmed

BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.

HCAR2 HCAR3

7.70e-06297231914599
Pubmed

Nicotinic acid receptor agonists.

HCAR2 HCAR3

7.70e-06297218983141
Pubmed

Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms.

HCAR2 HCAR3

7.70e-06297231366236
Pubmed

Mechanistic insight into the heme-independent interplay between iron and carbon monoxide in CFTR and Slo1 BKCa channels.

CFTR KCNMA1

7.70e-06297228474046
Pubmed

Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes.

HCAR2 HCAR3

7.70e-06297220655299
Pubmed

Evidence for constitutive dimerization of niacin receptor subtypes.

HCAR2 HCAR3

7.70e-06297220380810
Pubmed

GPR109A Expression in the Murine Min6 Pancreatic Beta Cell Line, and Its Relation with Glucose Metabolism and Inflammation.

HCAR2 HCAR3

7.70e-06297226116596
Pubmed

Expression and activation of the ketone body receptor HCAR2/GPR109A promotes preservation of retinal endothelial cell barrier function.

HCAR2 HCAR3

7.70e-06297235649469
Pubmed

GPR109A expressed on medullary thymic epithelial cells affects thymic Treg development.

HCAR2 HCAR3

7.70e-06297237595951
Pubmed

The hypophagic response to heat stress is not mediated by GPR109A or peripheral β-OH butyrate.

HCAR2 HCAR3

7.70e-06297226936786
Pubmed

Hydroxycarboxylic Acid Receptor 2, a Pleiotropically Linked Receptor for the Multiple Sclerosis Drug, Monomethyl Fumarate. Possible Implications for the Inflammatory Response.

HCAR2 HCAR3

7.70e-06297234084164
Pubmed

GPR109A gene deletion ameliorates gonadectomy-induced bone loss in mice.

HCAR2 HCAR3

7.70e-06297235489706
Pubmed

Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrences.

SIX1 DROSHA

7.70e-06297226802027
Pubmed

CFTR is required for PKA-regulated ATP sensitivity of Kir1.1 potassium channels in mouse kidney.

CFTR KCNJ1

7.70e-06297216470247
Pubmed

Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis.

HCAR2 HCAR3

7.70e-06297219561068
Pubmed

Loss or oncogenic mutation of DROSHA impairs kidney development and function, but is not sufficient for Wilms tumor formation.

SIX1 DROSHA SIX2

1.39e-051797330367465
Pubmed

Phagocytes from Mice Lacking the Sts Phosphatases Have an Enhanced Antifungal Response to Candida albicans.

UBASH3A UBASH3B

2.31e-05397230018105
Pubmed

A phosphatase activity of Sts-1 contributes to the suppression of TCR signaling.

UBASH3A UBASH3B

2.31e-05397217679096
Pubmed

Enhanced response of T cells from murine gammaherpesvirus 68-infected mice lacking the suppressor of T cell receptor signaling molecules Sts-1 and Sts-2.

UBASH3A UBASH3B

2.31e-05397224587276
Pubmed

Hyperhomocysteinemia is detrimental to pregnancy in mice and is associated with preterm birth.

HCAR2 HCAR3

2.31e-05397223579073
Pubmed

Short-chain fatty acids directly exert anti-inflammatory responses in podocytes and tubular epithelial cells exposed to high glucose.

HCAR2 HCAR3

2.31e-05397237215085
Pubmed

Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8.

HCAR2 HCAR3

2.31e-05397220033346
Pubmed

Niacin stimulates adiponectin secretion through the GPR109A receptor.

HCAR2 HCAR3

2.31e-05397219141678
Pubmed

Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice.

HCAR2 HCAR3

2.31e-05397220664170
Pubmed

Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.

HCAR2 HCAR3

2.31e-05397224226773
Pubmed

Activation of microglial GPR109A alleviates thermal hyperalgesia in female lupus mice by suppressing IL-18 and glutamatergic synaptic activity.

HCAR2 HCAR3

2.31e-05397234919284
Pubmed

Induction of the cystine/glutamate exchanger SLC7A11 in retinal pigment epithelial cells by the antipsoriatic drug monomethylfumarate.

HCAR2 HCAR3

2.31e-05397223404113
Pubmed

Niacin receptor GPR109A inhibits insulin secretion and is down-regulated in type 2 diabetic islet beta-cells.

HCAR2 HCAR3

2.31e-05397227570060
Pubmed

Molecular effects of Eya1 domain mutations causing organ defects in BOR syndrome.

SIX1 SIX2

2.31e-05397211734542
Pubmed

The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages.

HCAR2 HCAR3

2.31e-05397224845831
Pubmed

Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss.

SIX1 SIX2

2.31e-05397215735644
Pubmed

Oral Dimethyl Fumarate Targets HCA2-Expressing Skin Cells in the Imiquimod Mouse Model.

HCAR2 HCAR3

2.31e-05397235189149
Pubmed

The Butyrate-Producing Bacterium Clostridium butyricum Suppresses Clostridioides difficile Infection via Neutrophil- and Antimicrobial Cytokine-Dependent but GPR43/109a-Independent Mechanisms.

HCAR2 HCAR3

2.31e-05397233597149
Pubmed

Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells.

HCAR2 HCAR3

2.31e-05397217008386
Pubmed

Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression.

HCAR2 HCAR3

2.31e-05397222914621
Pubmed

The Sts proteins target tyrosine phosphorylated, ubiquitinated proteins within TCR signaling pathways.

UBASH3A UBASH3B

2.31e-05397219733910
Pubmed

Niacin protects against abdominal aortic aneurysm formation via GPR109A independent mechanisms: role of NAD+/nicotinamide.

HCAR2 HCAR3

2.31e-05397231710686
Cytoband2p13.2

NAT8 EXOC6B

2.88e-04129722p13.2
Cytoband12q24.31

HCAR2 HCAR1 HCAR3

6.68e-048097312q24.31
Cytoband1p31

DBT RPE65

9.04e-04219721p31
GeneFamilyHydroxy-carboxylic acid receptors

HCAR2 HCAR1 HCAR3

4.44e-083653200
GeneFamilySINE class homeoboxes

SIX1 SIX2

1.89e-046652525
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

ROCK2 DOCK10 BMX ARHGAP21 ARAP2

8.68e-04206655682
GeneFamilyTrafficking protein particle complex

TRAPPC8 TRAPPC10

1.13e-0314652772
GeneFamilyAminopeptidases|CD molecules

METAP1D METAP1

1.67e-0317652104
CoexpressionGSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP

ROCK2 ZNF154 CFTR DBT ZFHX4 NISCH RPE65

8.25e-06197967M7682
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_F-2fold-vs-M_top255_255

SLC22A23 TSC2 SALL2 DROSHA USP40 GREB1 HBZ SIX2

7.85e-06233928gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_250_F-2fold-vs-M
ToppCellLPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK8 DOCK10 UBASH3A ZAP70 CMA1 UBASH3B ARAP2

1.10e-0717497761aa89b56ebda0eba1ba675d5f036992967f670f
ToppCellLPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK8 DOCK10 UBASH3A ZAP70 CMA1 UBASH3B ARAP2

1.28e-071789777905621f5b2aa55324c5592d1d2fef763a5fa41f
ToppCellLPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK8 DOCK10 UBASH3A ZAP70 CMA1 UBASH3B ARAP2

1.28e-07178977f914092c20130207193f97c6044ae61a9a440a86
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RTTN DOCK10 RNF17 NCAPG2 SLC15A2 GRIFIN

1.55e-061639768dc0128eeede933537e3bcc5d6ec0322711552f3
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RTTN DOCK10 RNF17 NCAPG2 SLC15A2 GRIFIN

1.55e-06163976fd243ca223079033be480a24817a399f281fa4d4
ToppCellfacs-GAT-Fat-24m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

METAP1D ZAP70 KYAT1 CMA1 MED12L ARAP2

1.55e-06163976e58863a462cc504bced627f004a47890ee2307ce
ToppCellfacs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

UBASH3A ZNF865 ZAP70 DROSHA RBM19 UBASH3B

2.05e-06171976f1fdc0ec3399ed6955976d02be7e5fc329a64276
ToppCellLPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK10 UBASH3A ZAP70 CMA1 UBASH3B ARAP2

2.34e-0617597698cb577df466700e72d1bbc6689205ccf2e7fcba
ToppCellLPS_only-Lymphocytic_NKT-iNKT/MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK8 DOCK10 UBASH3A ZAP70 CMA1 UBASH3B

2.67e-06179976de3ddc1264e43727be50d69b81cc84a3c91812a2
ToppCellLPS_only-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK8 DOCK10 UBASH3A ZAP70 CMA1 UBASH3B

2.67e-06179976def981e97e3ff9019910c9af3861ca0d08eb0d0f
ToppCellControl-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK8 DOCK10 UBASH3A ZAP70 CMA1 ARAP2

3.03e-061839762c5707ada3442eb7100a2a5f9438d5a2ac53a9e1
ToppCellhuman_hepatoblastoma-NK.T_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)

DOCK8 DOCK10 UBASH3A EIF4E3 UBASH3B ARAP2

4.24e-06194976997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6
ToppCellCOVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class

CFTR SIX1 SLC15A2 SERPINB11 SDK1 SIX2

4.50e-06196976dd32046067d93b9484cfbf1d7826a436a3d9f0e9
ToppCellLPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_only / Treatment groups by lineage, cell group, cell type

DOCK8 DOCK10 UBASH3A ZAP70 CMA1 ARAP2

4.91e-06199976b62a756b5472972156d05051a58671a58bef1f16
ToppCellLPS_IL1RA_TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

DOCK8 DOCK10 UBASH3A ZAP70 CMA1 ARAP2

4.91e-06199976c23a53a20487a8abfeb91fa5fc9c06823dd657e9
ToppCellControl_saline-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|Control_saline / Treatment groups by lineage, cell group, cell type

DOCK8 DOCK10 UBASH3A ZAP70 CMA1 ARAP2

4.91e-061999762d7ebb9642f6fe0afd5e3fdc711ded54b73acd11
ToppCellLPS_IL1RA-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

DOCK8 DOCK10 UBASH3A ZAP70 CMA1 ARAP2

4.91e-061999760c743e4e88cbd2ca72e5161ca22a3e974b26f9b4
ToppCellLPS_anti-TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

DOCK8 DOCK10 UBASH3A ZAP70 CMA1 ARAP2

4.91e-061999760986d4342dc61e623d0dfc9f9870af86f72a8be3
ToppCellParenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CFTR HCAR1 SIX1 SLC15A2 SERPINB11 SDK1

5.05e-06200976b992eeddee38e6fe3564e9b1850f6b20b89bf47d
ToppCell18-Distal-Epithelial-Basal_cell|Distal / Age, Tissue, Lineage and Cell class

HCAR2 SLC22A23 SIX1 SLC15A2 ARAP2

2.49e-05158975183f445967e09e871c93d8e94781ed9fec894169
ToppCell5'-Adult-Appendix-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RNF166 DOCK10 UBASH3A ZAP70 ARAP2

2.49e-05158975da060f5b61c7088f700d138b02ea596adacf7d60
ToppCellfacs-Marrow-B-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADGRB2 ZAP70 KYAT1 RBM19 PGAP1

2.64e-0516097555f599df6e3b7a5a505df4b094c834281311d94a
ToppCellfacs-Marrow-B-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADGRB2 ZAP70 KYAT1 RBM19 PGAP1

2.64e-05160975296e53e1e0786346d38db2d4188b9a1c0430627b
ToppCellLPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK10 UBASH3A ZAP70 CMA1 UBASH3B

3.84e-05173975fde1fabb8d13d05998ac3f21ecb1fde6a7a2f337
ToppCell3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue

B3GLCT RTTN NCAPG2 PGAP1 ARHGAP21

3.84e-0517397567f0f0bf88eab69987b71d96b864ed2b14975adb
ToppCellLV-17._Lymphocyte|World / Chamber and Cluster_Paper

DOCK8 DOCK10 ZAP70 CMA1 ARAP2

3.84e-05173975212f013ff761cbab24a537071739867c08c402a4
ToppCellLPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK10 UBASH3A ZAP70 CMA1 UBASH3B

3.84e-05173975dcde3252ff96448d3a61039a4948c74ad321a218
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK8 SLC22A23 CFTR DOCK10 TBC1D1

3.95e-051749755f4436863a40f8bca46e2989bca66c02b6be88d4
ToppCellAdult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor

CFTR SIX1 SLC15A2 SERPINB11 SDK1

3.95e-051749757d2f802f493f19a068e097b2909a9000e2160266
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK8 SLC22A23 CFTR DOCK10 TBC1D1

4.06e-0517597577c16e615c0fb9c83f29d7e0a547be72635fac81
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK8 SLC22A23 CFTR DOCK10 TBC1D1

4.52e-05179975e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf
ToppCellAdult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor

CFTR SIX1 SLC15A2 SERPINB11 SDK1

4.52e-051799751fc1f252ca943a2f649d1e627f56acbf15f8e058
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

B3GLCT DOCK10 ZAP70 CYP2R1 TRAPPC10

4.52e-051799756bbb32d7e582a96cb3cfc3eb911b05d518e7d5e9
ToppCellfacs-Lung-EPCAM-24m-Myeloid-Dendritic_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B3GLCT DDX60 NAT8 ALMS1 SMCR8

4.64e-051809755b7d2336ed09d07f6b8dd91c1fa9c5ade633c104
ToppCellwk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

HCAR2 CFTR HCAR1 SIX1 SLC15A2

4.76e-05181975bab282cb0d9fc049f6fb094cf8b1fba104f4ea17
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK8 SLC22A23 CFTR DOCK10 TBC1D1

4.76e-0518197530729f0364f719c044712a51453e22dc2c1a232b
ToppCelldroplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ROCK2 DOCK8 DOCK10 PGAP1 EIF4E3

4.89e-05182975f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCellControl-Lymphocytic_NKT-iNKT/MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK8 DOCK10 UBASH3A CMA1 ARAP2

5.02e-0518397559e8d07556390828f7557ba3fd2f7d49851498b7
ToppCellEpithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor

CFTR SIX1 SLC15A2 SERPINB11 SDK1

5.02e-05183975940cbe298e9c53b5622af09264586ed823d3141f
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SLC25A46 FDXR GREB1 UBASH3B ARHGAP21

5.15e-05184975a6dee97ee4ef9d89e11d17339e0dadaea1210ce5
ToppCellwk_15-18-Epithelial-Proximal_epithelial-basal_proximal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

HCAR2 SIX1 HCAR3 SLC15A2 SIX2

5.15e-05184975575de705053da8b289670b5c40c1627c0833b5ed
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DOCK10 METAP1D BMX UBASH3B SDK1

5.28e-05185975caf4f57f2db9ff72a652c8573e16e7ab180ffc05
ToppCellhuman_hepatoblastoma-NK.T_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

DOCK8 DOCK10 UBASH3A UBASH3B ARAP2

5.70e-0518897571b7599e7e1d63cc0c8518c0501533755951d58f
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

RTTN NCAPG2 NAV2 UBASH3B RPE65

5.99e-05190975e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCellCOVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type

DOCK8 DOCK10 UBASH3A ZAP70 ARAP2

6.15e-051919755a4ad5ae5c2dbfb225158cb598ef649c26a48350
ToppCellCOVID-19-lung-CD8+_T_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type

DOCK8 DOCK10 UBASH3A ZAP70 ARAP2

6.15e-05191975543f8ae07cc2e6950c888115a5ca9445e3c0f618
ToppCellCOVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type

CFTR HCAR1 SIX1 SLC15A2 SERPINB11

6.30e-0519297559261098ccb52306f837f632ebaea45b90ad30fe
ToppCellwk_08-11-Epithelial-Proximal_epithelial-basal_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

HCAR2 SIX1 HCAR3 SLC15A2 SIX2

6.46e-0519397583d2dd823808a2b5ca1a6889eefb541ec042b24c
ToppCellCOVID-19-lung-CD4+_T_cells_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type

DOCK8 DOCK10 UBASH3A ZAP70 ARAP2

6.46e-05193975326fd2ce2c4b51e5a38f2a7a09f22f8f0e92735a
ToppCellCOVID-19-kidney-T-cells-1|COVID-19 / Disease (COVID-19 only), tissue and cell type

DOCK8 DOCK10 UBASH3A ZAP70 ARAP2

6.46e-051939755b84fa640cf30dea55fde53b810f850ff946d253
ToppCell5'-Adult-LargeIntestine-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RNF166 DOCK8 DOCK10 ZAP70 ARAP2

6.61e-051949759344556b375fd9267652cdca57b2cbd50a878a1e
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFTR HCAR1 SLC15A2 SERPINB11 SDK1

6.78e-051959752a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFTR HCAR1 SLC15A2 SERPINB11 SDK1

6.78e-05195975576142b4e75457c0973051bccc4163bd624496af
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFTR HCAR1 SLC15A2 SERPINB11 SDK1

6.78e-051959758f151066ad3ebd9661ea0b733f03c2ce1518f9ad
ToppCellmild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CWF19L2 RTTN ZAP70 PGAP1 ARAP2

7.11e-05197975e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCellLPS_IL1RA-Hematopoietic_Lymphocytic-Lymphocytic_NK/T|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

DOCK8 DOCK10 UBASH3A ZAP70 CMA1

7.28e-05198975a07590c6aa2c889b5d1a0413a6fba5b75bf5d70a
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CFTR SLC15A2 SERPINB11 SDK1 SIX2

7.28e-05198975af07a970afaa435c6433bb5c1cbff4c67af350c7
ToppCellControl_saline-Hematopoietic_Lymphocytic-Lymphocytic_NK/T|Control_saline / Treatment groups by lineage, cell group, cell type

DOCK8 DOCK10 UBASH3A ZAP70 ARAP2

7.28e-051989759663cf0c8296d3a7b0329cb725ccceeea7849cbc
ToppCellParenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CFTR HCAR1 SIX1 HCAR3 SERPINB11

7.28e-05198975fab3135f03cf23a9f04f0eed543a9dc181f39f5f
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CWF19L2 RTTN ZAP70 PGAP1 ARAP2

7.46e-05199975f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCellproximal-Epithelial-Differentiating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

HCAR2 SIX1 SLC15A2 SERPINB11 SIX2

7.46e-05199975c607346f60e5997e757e5a31cab412ab3734377b
ToppCellproximal-3-Epithelial-Differentiating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

HCAR2 SIX1 SLC15A2 SERPINB11 SIX2

7.46e-0519997512e07084fc2d5d4c418df564ccc0e132b056e549
ToppCellLPS_IL1RA-Hematopoietic_Lymphocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

DOCK8 DOCK10 UBASH3A ZAP70 CMA1

7.46e-05199975b6a700e101e0418be3ed51ce72a49596bb32d199
ToppCellproximal-Epithelial-Differentiating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

HCAR2 SIX1 SLC15A2 SERPINB11 SIX2

7.46e-0519997596a89a2578fad9a99c52d2cf9e26e06516a96568
ToppCellproximal-3-Epithelial-Proximal_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

HCAR2 SIX1 SLC15A2 KCNJ1 SIX2

7.64e-052009753a0c84f9a551fc2581ec3693481eada297d83f7b
ToppCellTracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK8 DOCK10 UBASH3A ZAP70 UBASH3B

7.64e-0520097568589705dbc84482b6c0a1a27dd552492c4e8c3d
ToppCellproximal-Epithelial-Proximal_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

HCAR2 SIX1 SLC15A2 KCNJ1 SIX2

7.64e-05200975de9aec87c86ad0a1bd5e0737c2aae0ec6f269bca
ToppCellParenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

DROSHA RBM19 ZBTB40 KANK4 TRAPPC10

7.64e-05200975be46efc899d06c55ee297bee3126f69bcdb2048b
ToppCellproximal-Epithelial-Proximal_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

HCAR2 SIX1 SLC15A2 KCNJ1 SIX2

7.64e-05200975ff2afa5c0352c214525129f9ff85afc139fe44d2
ToppCellFrontal_cortex-Macroglia-ASTROCYTE|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

NAT8 GRIFIN GREB1 RPE65

7.91e-05104974bf27bc52f440d1e94108b35ad85ed593201164c9
ToppCellFrontal_cortex-Macroglia-ASTROCYTE-Gja1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

NAT8 GRIFIN GREB1 RPE65

7.91e-0510497410e6c5b63c28d8c47e89ab130a7daf01700dd4e4
ToppCellPosterior_cortex-Macroglia-ASTROCYTE-Gja1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

NAT8 GRIFIN GREB1 RPE65

1.05e-04112974e30cd0b7b755c63081bbeed4e1a884b6640d34f8
ToppCellPosterior_cortex-Macroglia-ASTROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

NAT8 GRIFIN GREB1 RPE65

1.05e-041129741c0bcc6c972c50a9d950cd56b65efb8d778ec25a
ToppCellLPS-antiTNF-Hematopoietic_Mast-Mast_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

UBASH3A ZAP70 CMA1 MED12L

3.15e-0414997459aa1f2a5cbeba64c4529fb05f544db17fd8b188
ToppCellLPS-antiTNF-Hematopoietic_Mast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

UBASH3A ZAP70 CMA1 MED12L

3.15e-041499741527cdd98a2734cbf8ce4c6170557280b71c55cb
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZAP70 MOB2 FDXR G6PC2

3.32e-04151974def98dc2a8226295b62de2b7f1b587e03a4f038c
ToppCellIIH-CD8-exh_CD4|IIH / Condition, Cell_class and T cell subcluster

ZAP70 BBS7 ZBTB40 TRAPPC10

3.57e-04154974a2f51a3c5455fe2483e438375ea856afce8262fe
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RTTN DOCK10 NCAPG2 GRIFIN

3.84e-04157974ec433d2fe827abdb647be4176c231b7052482b6f
ToppCellRV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

DOCK10 KCNMA1 RPE65 SDK1

4.13e-0416097429c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCellChildren_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

HCAR1 SLC15A2 SERPINB11 SDK1

4.23e-041619742d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCelldroplet-Lung-30m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TMEM254 ZAP70 CMA1 ARAP2

4.23e-04161974cd4a736d0cec31477c6e8d3b07a04ede1559854b
ToppCelldroplet-Lung-30m-Hematologic-Lymphocytic_NK_ILC|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TMEM254 ZAP70 CMA1 ARAP2

4.23e-0416197428930ba576625b98cc15993d1499e9dc5edbb5a9
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9

DOCK8 DBT MEGF8 MED12L

4.32e-04162974810881210e015c788814e4fe8d7a24c929cf2621
ToppCelldroplet-Lung-30m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TMEM254 ZAP70 CMA1 ARAP2

4.32e-04162974ccba6d8d644fe56060ad388ec3a062b7e3b9f086
ToppCellfacs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UBASH3A ZAP70 ALMS1 CMA1

4.43e-04163974385b24e18df5ef92108483de312d6c85a1e6d145
ToppCellfacs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UBASH3A ZAP70 ALMS1 DNAJC11

4.43e-041639744af92b211d12c5b88b65bb746242cd702b545bd0
ToppCellfacs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UBASH3A ZAP70 ALMS1 CMA1

4.43e-041639748004cc0b3428be08b89957b563cd8799f822d931
ToppCellfacs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UBASH3A ZNF865 ZBTB40 ARAP2

4.43e-04163974a24db9d266a40f3bffe4f18d277bc269791b4560
ToppCellfacs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UBASH3A ZAP70 ALMS1 DNAJC11

4.43e-04163974d24774e0aa612322c22fdb3b314aef275fa01d68
ToppCellLPS_only-Epithelial_airway-Club_cells-Airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SIX1 SLC15A2 SERPINB11 SIX2

4.53e-04164974b1243b10591e1e15a94952e39ffbf382eae6aae8
ToppCellfacs-BAT-Fat-3m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UBASH3A ZAP70 CMA1 UBASH3B

4.53e-04164974cbdb7e893cb3959b9920c0c7c535ace03a5f4986
ToppCellLPS_only-Epithelial_airway-Club_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SIX1 SLC15A2 SERPINB11 SIX2

4.53e-04164974c5b2001280a43da855017361a3f6071a0e492848
ToppCell3'-GW_trimst-1-LargeIntestine-Hematopoietic-B_cells-CLP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DOCK8 UBASH3A UBASH3B ARAP2

4.53e-04164974f5cacd7b2329cb0c7c1696eb4d8f89a4bbd9dda1
ToppCellLPS_only-Epithelial_airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SIX1 SLC15A2 SERPINB11 SIX2

4.53e-0416497456e6934e6c7503a300d7be06762d45a1d6f1ae0f
ToppCell5'-Adult-Appendix-Hematopoietic-T_cells-Activated_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DOCK8 DOCK10 METAP1D ZAP70

4.53e-0416497424fdea5113d92b96f56b06dd2449910a3c785e69
ToppCellLPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CFTR SIX1 SLC15A2 SERPINB11

4.74e-041669741df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d
ToppCellLPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CFTR SIX1 SLC15A2 SERPINB11

4.74e-041669749628522e7af8f8edca733588a364ab2454ac5ca5
ToppCell356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells)

CWF19L2 FAXDC2 UBASH3A ZW10

4.74e-04166974c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d
ToppCelldroplet-Lung-nan-21m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RTTN ADGRB2 ARHGAP35 CMA1

4.74e-0416697421ba5fd755c0fb31ada42a1b5d60bede0153323d
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

B3GLCT UBASH3A NCAPG2 PGAP1

4.85e-04167974c0c944eae0514dc8e00d0c2892a0792e157695ec
Drugdihydropinosylvin

CFTR UBASH3A UBASH3B

2.99e-074973CID000442700
DrugNs004

CFTR KYAT1 RBM19 KCNMA1

7.06e-0717974CID005311330
Drugd4TMP

TSC2 KYAT1 STT3A KCNMA1

1.02e-0532974CID000461278
Drugthiacloprid

HCAR2 ZBTB33 HCAR3 MED12L

1.30e-0534974CID000115224
DrugEPTC

HCAR2 KYAT1 HCAR3 FDXR

1.46e-0535974CID000012968
DrugPregnenolone [145-13-1]; Up 200; 12.6uM; MCF7; HT_HG-U133A

DBT ARHGAP35 KYAT1 PTPRS RBM19 EXOC6B GREB1

1.55e-051879772856_UP
Drug2q92

METAP1D METAP1

1.80e-052972CID000736027
Druga0 4

METAP1D METAP1

1.80e-052972CID000834826
Drugp1394

METAP1D METAP1

1.80e-052972CID000736255
Drug2q95

METAP1D METAP1

1.80e-052972CID000763808
Drug5-bromothiophene-2-carboxylic acid

METAP1D METAP1

1.80e-052972CID000349115
Drugy E7

METAP1D METAP1

1.80e-052972CID000869249
Drugimidazo[1,2-c]pyrimidine

ZAP70 FAM50A

1.80e-052972CID009548860
Drug2q93

METAP1D METAP1

1.80e-052972CID000776315
Drug2q96

METAP1D METAP1

1.80e-052972CID014163672
DrugDB08757

METAP1D METAP1

1.80e-052972CID004697633
DrugN-(5-chloroquinolin-8-yl)methanesulfonamide

METAP1D METAP1

1.80e-052972CID004014900
Drug5-bromofuran-2-carboxylic acid

METAP1D METAP1

1.80e-052972CID000068511
DrugMet-Gly-Met-Met

METAP1D METAP1

1.80e-052972CID005062077
Drugmg mm

METAP1D METAP1

1.80e-052972CID000194857
Drugikarugamycin; Down 200; 2uM; MCF7; HT_HG-U133A_EA

ROCK2 KYAT1 ALMS1 BBS7 PGAP1 NAV2 POFUT1

1.90e-05193977866_DN
DrugMenadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A

DDX60 DOCK10 DBT ARHGAP35 RBM19 NAV2 SIX2

1.97e-051949774662_DN
DrugNSC133880

METAP1D METAP1

5.37e-053972CID000281246
Drugoctyl sulfide

CFTR DBT

5.37e-053972CID000075901
Drugmethylmercury cysteine

RNF166 DDX60 KYAT1 STT3A

6.63e-0551974ctd:C030589
Drugtetramethylammonium

HCAR2 PTDSS1 HCAR3 KCNJ1

7.72e-0553974CID000006380
DrugNiacin

HCAR2 HCAR3

1.07e-044972DB00627
Drugpaspalinine

CFTR KCNMA1

1.07e-044972CID000114727
DrugMet-Ala-Ser

METAP1D METAP1

1.07e-044972CID000444641
DrugEudragit RS

STT3A TBC1D1 CMA1

1.09e-0422973CID000104931
DiseaseX-23590 measurement

NAT8 ALMS1

1.00e-052942EFO_0800850
Diseaseblood N-acetyl-2-aminoadipate measurement

NAT8 ALMS1

1.00e-052942EFO_0022202
DiseaseX-12753 measurement

NAT8 ALMS1

1.00e-052942EFO_0800727
DiseaseCiliopathies

CFTR TSC2 NPHP4 BBS7 RPE65

2.77e-05110945C4277690
DiseaseN-acetylcitrulline measurement

NAT8 ALMS1

3.01e-053942EFO_0800028
DiseaseN2,N5-diacetylornithine measurement

NAT8 ALMS1

3.01e-053942EFO_0800070
DiseaseN-acetyl-3-methylhistidine measurement

NAT8 ALMS1

3.01e-053942EFO_0800044
Diseasemetabolic syndrome

SEC16B HCAR2 APOA5 HCAR3 G6PC2 ARAP2

4.46e-05200946EFO_0000195
DiseaseX-12125 measurement

NAT8 ALMS1

6.00e-054942EFO_0800707
Diseaseobesity (implicated_via_orthology)

SEC16B ALMS1 ZFHX4 SLC15A2 MED12L SDK1

6.66e-05215946DOID:9970 (implicated_via_orthology)
Disease2-hydroxyoctanoate measurement

NAT8 ALMS1

9.98e-055942EFO_0800192
DiseaseN-acetylglutamate measurement

NAT8 ALMS1

9.98e-055942EFO_0800005
DiseaseN2-acetyl,N6-methyllysine measurement

NAT8 ALMS1

9.98e-055942EFO_0800109
DiseaseBilateral Wilms Tumor

SIX1 DROSHA SIX2

1.08e-0429943C2930471
DiseaseN-acetyltyrosine measurement

NAT8 ALMS1

1.49e-046942EFO_0020021
DiseaseNephroblastoma

SIX1 DROSHA SIX2

2.07e-0436943C0027708
DiseaseN-acetyl-1-methylhistidine measurement

NAT8 ALMS1

2.09e-047942EFO_0800065
DiseaseX-11787 measurement

NAT8 ALMS1

2.78e-048942EFO_0021258
Disease2-aminooctanoate measurement

NAT8 ALMS1

2.78e-048942EFO_0800349
DiseaseN-acetylleucine measurement

NAT8 ALMS1

3.56e-049942EFO_0800116
DiseaseN6-acetyllysine measurement

NAT8 ALMS1

4.44e-0410942EFO_0800036
Diseasehigh density lipoprotein cholesterol measurement, multiple sclerosis

SLC15A2 UBASH3B

4.44e-0410942EFO_0004612, MONDO_0005301
Disease2-ketocaprylate measurement

NAT8 ALMS1

4.44e-0410942EFO_0800110
DiseaseN-acetylphenylalanine measurement

NAT8 ALMS1

5.42e-0411942EFO_0800019
DiseaseIntellectual Disability

DOCK8 RTTN STT3A BBS7 MED12L ZBTB40 WDR45B

5.76e-04447947C3714756
DiseaseDisorder of eye

B3GLCT NPHP4 ALMS1 BBS7 RPE65

5.97e-04212945C0015397
Diseasedystonia (implicated_via_orthology)

TOR1A KCNMA1

6.49e-0412942DOID:543 (implicated_via_orthology)
Diseasemethionine sulfone measurement

NAT8 ALMS1

6.49e-0412942EFO_0800072
DiseaseN-delta-acetylornithine measurement

NAT8 ALMS1

6.49e-0412942EFO_0800067
DiseaseN-acetyl-2-aminooctanoate measurement

NAT8 ALMS1

6.49e-0412942EFO_0800567
DiseaseSquamous cell carcinoma

HCAR2 DOCK8 TSC2 HCAR3

6.77e-04124944C0007137
DiseaseCakut

TBC1D1 SIX2

7.65e-0413942C1968949
DiseaseN-acetylglutamine measurement

NAT8 ALMS1

7.65e-0413942EFO_0800017
Diseasetriglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement

SEC16B HCAR2 APOA5 HCAR1 HCAR3

7.80e-04225945EFO_0008317, EFO_0020947
DiseaseMetabolic Bone Disorder

CYP2R1 KCNMA1

8.91e-0414942C0005944
DiseaseOsteopenia

CYP2R1 KCNMA1

1.03e-0315942C0029453
DiseaseMental Retardation, Psychosocial

DOCK8 BBS7 ZBTB40 WDR45B

1.04e-03139944C0025363
DiseaseProfound Mental Retardation

DOCK8 BBS7 ZBTB40 WDR45B

1.04e-03139944C0020796
DiseaseMental deficiency

DOCK8 BBS7 ZBTB40 WDR45B

1.04e-03139944C0917816
DiseaseN-acetylarginine measurement

NAT8 ALMS1

1.17e-0316942EFO_0021429
Diseasevery low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio

SEC16B HCAR2 APOA5 HCAR1 HCAR3

1.59e-03264945EFO_0008317, EFO_0020944
Diseaseblood metabolite measurement

NAT8 ALMS1

1.66e-0319942EFO_0005664
Diseasecomplex trait

APOA5 OR10J6P KANK4 G6PC2 UBASH3B

1.78e-03271945EFO_0010578
Diseasehigh density lipoprotein particle size measurement

APOA5 HCAR1 HCAR3 NISCH

2.17e-03170944EFO_0008592
Diseasemortality

SLC25A46 KCNMA1 RPE65 ARAP2

2.31e-03173944EFO_0004352
Diseasemean corpuscular hemoglobin concentration

HCAR2 APOA5 RTTN TSC2 ZDHHC4 STT3A HCAR3 BBS7 HBZ ARHGAP21

2.74e-0311059410EFO_0004528
Diseaseatopic dermatitis (is_implicated_in)

DOCK8 CMA1

3.10e-0326942DOID:3310 (is_implicated_in)

Protein segments in the cluster

PeptideGeneStartEntry
HFYHKQHLCLVFEPL

PRPF4B

756

Q13523
HSELYHELNQKFHTF

ADGRB2

1481

O60241
YHIKPLSLHQRTHFI

BBS7

486

Q8IWZ6
QPYFETLFHKALNLH

CFTR

1071

P13569
KDYLSHQVPISFHKH

B3GLCT

451

Q6Y288
LPFIDSQHVIHKYFL

DPM2

31

O94777
CFDSIPKLIHYHQHN

BMX

366

P51813
FYTAQHLLKHPQAHV

FDXR

51

P22570
VFRSAKFYIHHPVHL

ALMS1

3476

Q8TCU4
VHHTGRFKELFHPYA

APOA5

181

Q6Q788
LYHNKFSDFPQHDIH

ARAP2

866

Q8WZ64
VSFQHPHKYLLHYLV

CCNQ

136

Q8N1B3
ELEKIFHFTHYPDVH

ISX

96

Q2M1V0
FHFTHYPDVHIRSQL

ISX

101

Q2M1V0
HLAYSKFHHVPLYLE

RBM19

641

Q9Y4C8
LHGHLNTLYVHFILF

MOB2

171

Q70IA6
KYSHPHHFLKTTAAL

DBT

46

P11182
PFLQSHREHHYAKTS

YWHAH-AS1

81

Q9Y442
YGFILHAVFHLPSHD

OR52D1

221

Q9H346
IPHSFALISYQHKFQ

DNAJC11

301

Q9NVH1
IHKLFHTAPNVPHYA

METAP1

296

P53582
HRIFSSPLNHIYLHK

METAP1D

16

Q6UB28
SYHLPLAHHIQLIFD

MED12L

821

Q86YW9
ASNFHYHELKHIVFV

KCNMA1

866

Q12791
HFIIPKSKEHHFVFS

GREB1

1506

Q4ZG55
KFLQHHSHLFFPLSL

GREB1

1816

Q4ZG55
FPLAEYRTKHEIHHT

ZBTB33

531

Q86T24
YFRVVHPHHALNKIS

HCAR2

126

Q8TDS4
HLHYHEPSNLVFVSF

DDX60

1441

Q8IY21
KNTLNDVLFYHFLHH

EFCAB9

41

A8MZ26
FAHVIEDQHKFPHYF

CWF19L2

831

Q2TBE0
PHEHHALKSSRFYLL

MEGF8

2601

Q7Z7M0
HYPALKTLEHLEHTY

EXOC6B

156

Q9Y2D4
HTDVHLHTPMYFFLA

OR2C3

51

Q8N628
PTQLYSHHFQRFKEH

PRPF39

236

Q86UA1
ITFKAVFYKPHEEHH

EIF4E3

201

Q8N5X7
YFHTSLNHPHIVAVV

NPHP4

96

O75161
ITHLKPHTFYNFVLT

PTPRS

1086

Q13332
SHPQTKTYFPHFDLH

HBZ

36

P02008
PSPEFHDYHHLKFNQ

FAXDC2

271

Q96IV6
PTQLHEKHHILFSFY

DOCK10

751

Q96BY6
PAKLTVNHHLLFTFY

DOCK8

636

Q8NF50
FFTALLQRFHLHFPH

CYP2R1

461

Q6VVX0
YIKEDLIIPHHHSFY

FAM50A

251

Q14320
LIIPHHHSFYDFIVT

FAM50A

256

Q14320
LYHFLQIPTHEEHLF

G6PC2

306

Q9NQR9
YLHEVQPHSPHFLKL

KANK4

801

Q5T7N3
ADRYFKVVHPHHAVN

HCAR1

111

Q9BXC0
AEHFHVYAPEHKVLQ

GRIFIN

91

A4D1Z8
HHGHITNLKKFTAYF

SDK1

931

Q7Z5N4
SQDFHFHLKYHNLSL

SLC15A2

461

Q16348
KQAFFHLYHPLGSQH

SALL2

271

Q9Y467
IEYQHHKPPFTNLHV

POFUT1

71

Q9H488
HKHHITLFVVFLILY

OR10J6P

21

Q8NGY7
ITTLDHHLHTPVYFF

OR14A16

46

Q8NHC5
HHLHTPVYFFLKNLS

OR14A16

51

Q8NHC5
SFSYHQHFPLIKEII

RTTN

581

Q86VV8
LVATEYLFIHFPDHH

DROSHA

1156

Q9NRR4
LLHKFDFKEGHVTYH

RPE65

66

Q16518
LQHLLHRHKFSYDTF

RNF166

201

Q96A37
LHNQKGYFLHHIIFA

SLC22A23

591

A1A5C7
YFRVVHPHHALNKIS

HCAR3

126

P49019
VSIFYSVPHQKHFDH

KYAT1

381

Q16773
VFLQKYPHTHLVHQA

MSTN

316

O14793
SLHFSLPLFHHARYE

NAV2

1651

Q8IVL1
SAAIYHVLHFFHITI

STT3A

96

P46977
LYKILESHQFSPHNH

SIX1

66

Q15475
LYHHFIRHPSKHFEE

PGAP1

321

Q75T13
KVFTFTHNPHQLHVF

WDR45B

121

Q5MNZ6
KANHPFLFFIRHTHT

SERPINB11

366

Q96P15
DALILKHIHFVYHPT

ARHGAP35

541

Q9NRY4
SKAFLYTFCHHLHLP

SMCR8

856

Q8TEV9
QFRHPKYNTSTLHHD

CMA1

96

P23946
PVHSKVREVLSYFHH

NCAPG2

301

Q86XI2
LRSHFEKNTTLHYHP

RNF17

656

Q9BXT8
YVLSLVHDVRFHHFP

ZAP70

46

P43403
LKSHQEHVHGQFFPY

ZFHX4

1916

Q86UP3
FKHFLGLVTHKYVHL

ZNF865

801

P0CJ78
SDYVHLFVATLHFPH

TOR1A

126

O14656
YHAQHYHLTPFTVIN

SLC25A46

131

Q96AG3
LLHYLFHTRNHTFIV

ZDHHC4

56

Q9NPG8
VHKLIHNSHDPSYFA

TBC1D1

101

Q86TI0
VTPRVLAHFLHFHFY

NISCH

106

Q9Y2I1
ICHKGHEFIPTLYHF

ROCK2

1256

O75116
LYKILESHQFSPHNH

SIX2

66

Q9NPC8
HVPFGHYTVKTDHLV

SEC16B

571

Q96JE7
LLYHQHVHTLETLFK

ZNF319

386

Q9P2F9
FYQKPHLTEHQKTHT

ZNF25

211

P17030
KTSLHYPESFNHPFH

TRAPPC8

1311

Q9Y2L5
FFTYHSSLIKHQKVH

ZNF154

281

Q13106
LHVTLAYHFQASHLP

UBASH3B

211

Q8TF42
DVRLFKYLPHHSAHS

TRAPPC10

1161

P48553
LPEHHYETLKFLSAH

ARHGAP21

1266

Q5T5U3
LGPFTQYLVDHHHTL

TMEM254

46

Q8TBM7
TFELHLHLGPQYHFF

USP40

526

Q9NVE5
FLKHIFVFQASHPLS

PTDSS1

306

P48651
VSHIQLHYKHSYTLP

TSC2

591

P49815
LSIHLHTFHNIEDPY

ZBTB40

936

Q9NUA8
TLAHKFYPHHQRTLE

UBASH3A

236

P57075
FHLFHDVVPTYHKEN

ZW10

516

O43264
VPHSVHHKINCFFYL

UNQ6126/PRO20091

76

Q6UXV3
LTIYHVIDHNSPFFH

KCNJ1

266

P48048
HTVHFIYHLPSSKVG

NAT8

211

Q9UHE5